# A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas

> **NCT00045708** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 57 (actual)

## Conditions studied

- Adult Anaplastic Astrocytoma
- Adult Giant Cell Glioblastoma
- Adult Gliosarcoma
- Recurrent Adult Brain Tumor

## Interventions

- **DRUG:** ixabepilone
- **OTHER:** pharmacological study
- **DRUG:** Anticonvulsant

## Key facts

- **NCT ID:** NCT00045708
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00045708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00045708, "A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT00045708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*